Private
The Biomedical Advanced Research and Development Authority (BARDA) and the U.S. Department of Defense (DoD) announced a deal to work with Smiths Medical to expand the domestic manufacturing capacity for safety needles and syringes.
BARDA, along with the DoD’s Joint Program Executive Office for... Read More »
The COVAX Facility -- an organization created to guarantee quick and equitable access to COVID-19 vaccines throughout the world -- has garnered the interest of 75 countries and plans to support as many as 90 lower-income countries through Gavi, the Vaccine Alliance’s Advance Market Commitment... Read More »
U.S. Sen. Steve Daines (R-MT) is requesting more funding for potential COVID-19 vaccines in any new coronavirus relief package.
“As you continue your work on critical legislation to respond to the COVID-19 crisis, I write to you today to urge your support for robust funding that will help... Read More »
Sandia National Laboratories is turning to machine learning to assist COVID-19 researchers in combing through existing coronavirus studies and data.
Through a mix of algorithms, analytics, and data mining, Sandia wants to make it easy for scientists to find the data they need right at their... Read More »
Moderna, Inc. expects to begin a 30,000 participant phase 3 study of its COVID-19 vaccine candidate later this month, following the publication of an interim phase 1 analysis that demonstrated a generally safe and well-tolerated reaction among a small group of healthy adults.
The results,... Read More »
The University of Queensland’s COVID-19 vaccine candidate reached a milestone as the first participants were enrolled in its Phase 1 clinical trial.
The university’s vaccine is the seventh that is part of the portfolio of vaccines funded by the Coalition for Epidemic Preparedness... Read More »
The Johns Hopkins Applied Physics Laboratory (APL) has partnered with the Department of Homeland Security (DHS) as a means of aiding state and local governments with cyber defense efforts.
The APL and DHS’s Cybersecurity and Infrastructure Security Agency (CISA) have enlisted the assistance of... Read More »
Boeing recently announced that it has secured an Air Force contract to build the initial eight F-15EX advanced fighter jets and an overall Indefinite Delivery Indefinite Quantity pact.
Officials said the agreement calls for $1.2 billion for the first allotment of aircraft, with the overall... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) and Sichuan Clover Biopharmaceuticals, Inc. expanded their partnership last week to guarantee the rapid development and manufacturing of the company’s protein-based COVID-19 vaccine candidate.
Known as S-Trimer, the vaccine is based on... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) and Department of Defense penned two technology investment agreements focused on boosting domestic manufacturing last week, with Retractable Technologies, Inc. (RTI) and Becton, Dickinson and Co. (BD), respectively.
In both... Read More »
The Department of Defense (DOD) has selected Northrop Grumman Corporation’s Forward Area Air Defense Command and Control (FAAD C2) system for future Counter-Small Unmanned Aerial System (C-sUAS) procurements.
“Our FAAD C2 has been saving lives at Forward Operating Bases and locations around... Read More »
Sandia National Laboratories personnel is offering design specifications for an outdoor shelter shielding healthcare workers conducting COVID-19 testing on its licensing and technology transfer website.
The free design and instruction manual would yield a low-cost, drive-up outdoor shelter. The... Read More »
Streamlining processes this week, the National Institute of Allergy and Infectious Diseases (NIAID) created a new clinical trials network to gather thousands of volunteers together for testing of various investigational vaccines and monoclonal antibodies for use against COVID-19.
NIAID -- a part... Read More »
Pressing forward with a potential antibody treatment for COVID-19 known as REGN-COV2, the U.S. Departments of Health and Human Services (HHS) and Defense (DoD) announced an agreement with Regeneron, Inc. this week that will culminate in a commercial-scale manufacturing demonstration.
REGN-COV2... Read More »
Rewards are rolling out from the Trump administration’s Operation Warp Speed this week, including $1.6 billion -- allotted from the Departments of Health and Human Services (HHS) and Defense (DoD) -- given to Novavax, Inc. for 100 million doses of a possible COVID-19 vaccine.
While the... Read More »
A new partnership for the Biomedical Advanced Research and Development Authority’s (BARDA) ongoing efforts to grapple with COVID-19 has united it with Chembio Diagnostics, Inc. in an attempt to create a point-of-care in vitro diagnostic test.
If successful, that test would be capable of... Read More »
Emergent BioSolutions Inc. struck a five-year manufacturing services agreement with Johnson & Johnson's Janssen Pharmaceuticals Inc. for its investigational COVID-19 vaccine.
Emergent will provide contract development and manufacturing (CDMO) services for large-scale drug substance... Read More »
Smiths Detection -- a leader in threat detection and screening technologies for aviation, ports, and borders, urban security and defense -- has launched new algorithms that enhance its HI-SCAN 10080 XCT explosive-detection system (EDS) scanner’s detection capabilities.
Smiths iCMORE detection... Read More »
The National Consortium for the Study of Terrorism and Responses to Terrorism (START) has joined the RESOLVE Network, a group of individuals and organizations focused on issues related to violent extremism and community resilience.
START Director William Braniff serves on the RESOLVE Network’s... Read More »
First Responder Network Authority (FirstNet) officials recently joined a trio of agencies in presenting Accelerate R2 Network (R2 Network) Challenge awards.
The initiative serves as an interagency program connecting stakeholder response and resilience. The Department of Commerce, Economic... Read More »
Expanding on an existing partnership, the Biomedical Advanced Research and Development Authority (BARDA) and Sonica Health announced last week that they will work together to create a wearable patch capable of monitoring for COVID-19 infections.
The device is meant for high-risk clinical... Read More »
BAE Systems Applied Intelligence and Acuminor are developing new technology to help banks identify transactional behavior linked to human trafficking.
They are working on a trial with a major Nordic bank for their new solution to test the effectiveness of its financial crime detection systems.... Read More »
The U.S. Department of Health and Human Services (HHS) struck an agreement to secure large supplies of the drug remdesivir from Gilead Sciences.
HHS has secured more than 500,000 treatment courses of remdesivir -- the first authorized therapeutic for COVID-19 -- for U.S. hospitals through... Read More »
The Coalition for Epidemic Preparedness Innovations (CEPI) is part of an effort to ensure equitable access to COVID-19 vaccines for all countries.
CEPI helped launch the COVID-19 Vaccine Global Access Facility (COVAX), part of the ACT Accelerator, which was established to ensure that the... Read More »
FirstNet, the broadband platform for public safety, has launched a pair of Vermont purpose-built cell sites in North Bennington and West Bridgewater.
“We worked hand-in-hand with Vermont’s public safety community to understand their needs for the network,” FirstNet Authority CEO Edward... Read More »
Scientists did not anticipate the initial threat of SARS-CoV-2, but what if they could have.
In a commentary released this month by Amesh Adalja, a senior scholar at Johns Hopkins University Center for Health Security, society could be prepared for the next pandemic through a medical... Read More »
A new platform, SolaVAX, aims to help inactivate the SARS-CoV-2 virus -- the virus which causes COVID-19 -- in patients, and its progress will be a joint project of its creators at Colorado State University and the Biomedical Advanced Research and Development Authority (BARDA).
SolaVAX was... Read More »
Pharma company Moderna will collaborate with Catalent – a company that develops technologies and manufacturing solutions for drugs and consumer health products – on Moderna’s mRNA-based COVID-19 vaccine candidate.
Catalent will provide vial filling and packaging capacity, as well as... Read More »
The Coalition for Epidemic Preparedness Innovations, or CEPI, signed an agreement with Stevanato Group to supply glass vials to hold vaccine for the COVID-19 virus once it is developed.
Stevanato, based in Italy, will supply 100 million Type 1 Borosilicate glass vials to hold up to 2 billion... Read More »
The Department of Defense (DoD) recently awarded a $59 million contract to Alion Science and Technology to implement weapons systems research and development.
The scope of work would aid the Navy Warfare Development Command (NWDC) Red Cell, information operations cell, and electromagnetic... Read More »
An existing partnership between vaccine company Sanofi Pasteur and clinical-stage mRNA therapeutics company Translate Bio expanded this week to include development of mRNA vaccines for infectious diseases.
The companies originally began collaborating in 2018. Now, their union will focus on... Read More »
Clover Biopharmaceuticals began phase 1 clinical trials in Perth, Australia, on its COVID-19 vaccine candidate, which is supported by the Coalition for Epidemic Preparedness Innovations (CEPI).
CEPI has provided up to $3.5 million for Clover to support the preparation and initiation of a trial... Read More »
Both INOVIO’s CELLECTRA 3PSP smart device and CELLECTRA 2000 devices will benefit from a $71 million contract with the U.S. Department of Defense (DoD), in the hopes of scaling up DNA delivery devices for the company’s potential COVID-19 vaccine, INO-4800.
Both devices deliver INO-4800... Read More »
A public-private partnership between the Biomedical Advanced Research and Development Authority (BARDA) and MBio Diagnostics aims to create a COVID-19 serology test capable of providing results within five minutes.
The test is a point-of-care diagnostic that tests for human anti-SARS-CoV-2... Read More »
Sandia National Laboratories recently announced that it was working with medical device manufacturers to test mask materials and with local hospitals to evaluate N95 mask cleaning methods to boost the availability of masks in the beleaguered United States healthcare system.
This assistance is... Read More »
